Effectiveness and cost-effectiveness of different immunization strategies against whooping cough to reduce child morbidity and mortality

Health Policy. 2014 Mar;115(1):82-91. doi: 10.1016/j.healthpol.2013.12.007. Epub 2013 Dec 28.

Abstract

Introduction: In the last years there has been a significant increase in reported cases of pertussis in developed countries, in spite of high rates of childhood immunization. Health institutions have recommended different vaccination strategies to reduce child morbidity and mortality: vaccination of adolescents and adults, pregnant women, people in contact with the newborn (cocoon strategy) and health care workers. The aim of this paper is to review the scientific evidence supporting these recommendations.

Methods: Systematic review on the effectiveness and cost-effectiveness of the above strategies for the reduction of morbidity and mortality from pertussis in infants under 12 months. The electronic databases Medline, PreMedline, Embase, CRD, Cochrane Central, and Trip Database were consulted from 1990 to October 2012. The evidence was assessed using the GRADE system.

Results: There were eight studies on the efficacy or safety of the strategies analyzed, and 18 economic evaluations. Direct evidence on the efficacy of these strategies is scarce. Economic evaluations suggest that vaccination of adolescents and adults would be cost-effective, although there is major uncertainty over the parameters used.

Conclusions: From the perspective of health technology assessment, there is insufficient evidence to recommend the vaccination strategies evaluated.

Keywords: Adolescent; Adult; Diphtheria–tetanus–pertussis vaccine; Health personnel; Immunization; Whooping cough.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cost-Benefit Analysis
  • Female
  • Health Policy / economics
  • Humans
  • Pertussis Vaccine / economics
  • Pertussis Vaccine / therapeutic use*
  • Pregnancy
  • Program Evaluation
  • Whooping Cough / economics
  • Whooping Cough / mortality
  • Whooping Cough / prevention & control*

Substances

  • Pertussis Vaccine